“We, to date, raised quite a bit of capital, 240 million, I think. If I did all the math correctly, about 135 million was equity, and the rest is diluted money, including some of the government grants. We've been very lucky to actually be in an age who supported us at Stanford in the early years of business. They continue to support us because I think they believe we're doing good things for the healthcare system and for society. This is a very exciting endeavor. We've been one of the lucky ones to be able to get this to this stage. It is a very exciting time for the business.”